Last 12 months
Inside the activity.
0 purchase rows · 93 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 16 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 49 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 19, 2018 Filed Jan 23, 2018 21:56 UTC |
Sachdev AmitEVP, CRO
|
SaleCommon Stock | 700 | $159.35 | $111,545.00 |
DisclosureSEC source: 0001209191-18-004928 · doc4.xml · nonDerivative · entry 5 Sachdev Amit · CIK 0001406338 · EVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,163 F1 · kind: Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $159.35 (range $159.27 to $159.45). Read SEC document |
| January 19, 2018 Filed Jan 23, 2018 21:56 UTC |
Sachdev AmitEVP, CRO
|
SaleCommon Stock | 13,312 | $158.59 | $2,111,150.08 |
DisclosureSEC source: 0001209191-18-004928 · doc4.xml · nonDerivative · entry 4 Sachdev Amit · CIK 0001406338 · EVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,863 F1 · kind: Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $158.59 (range $158.20 to $159.10). Read SEC document |
| January 19, 2018 Filed Jan 23, 2018 21:56 UTC |
Sachdev AmitEVP, CRO
|
SaleCommon Stock | 18,410 | $157.67 | $2,902,704.70 |
DisclosureSEC source: 0001209191-18-004928 · doc4.xml · nonDerivative · entry 3 Sachdev Amit · CIK 0001406338 · EVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,175 F1 · kind: Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $157.67 (range $157.18 to $158.17). F3 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| January 19, 2018 Filed Jan 23, 2018 21:56 UTC |
Sachdev AmitEVP, CRO
|
Exercise / conversionCommon Stock | 13,750 | $83.36 | $1,146,200.00 |
DisclosureSEC source: 0001209191-18-004928 · doc4.xml · nonDerivative · entry 2 Sachdev Amit · CIK 0001406338 · EVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,585 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 19, 2018 Filed Jan 23, 2018 21:56 UTC |
Sachdev AmitEVP, CRO
|
Exercise / conversionCommon Stock | 18,672 | $77.31 | $1,443,532.32 |
DisclosureSEC source: 0001209191-18-004928 · doc4.xml · nonDerivative · entry 1 Sachdev Amit · CIK 0001406338 · EVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,835 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 21:34 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,125 | $0.00 Strike: $96.87 | $0.00 |
DisclosureSEC source: 0001209191-18-003955 · doc4.xml · derivative · entry 4 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,250 Underlying: Common Stock · 2,125 shares Expires 2024-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests in 16 quarterly installments from 7/15/2014. Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 21:34 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
SaleCommon Stock | 2,125 | $158.28 | $336,345.00 |
DisclosureSEC source: 0001209191-18-003955 · doc4.xml · nonDerivative · entry 2 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,952 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company-approved trading plan under Rule 10b5-1. Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 21:34 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
Exercise / conversionCommon Stock | 2,125 | $96.87 | $205,848.75 |
DisclosureSEC source: 0001209191-18-003955 · doc4.xml · nonDerivative · entry 1 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,077 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 21:38 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,719 | $0.00 Strike: $96.87 | $0.00 |
DisclosureSEC source: 0001209191-18-003958 · doc4.xml · derivative · entry 5 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,438 Underlying: Common Stock · 1,719 shares Expires 2024-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vests in 16 quarterly installments from 7/15/2014. Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 21:38 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
SaleCommon Stock | 300 | $159.04 | $47,712.00 |
DisclosureSEC source: 0001209191-18-003958 · doc4.xml · nonDerivative · entry 4 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,424 F1 · kind: Transaction made pursuant to Dr. Chodakewitz's company-approved trading plan under Rule 10b5-1. Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 21:38 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
SaleCommon Stock | 900 | $157.54 | $141,786.00 |
DisclosureSEC source: 0001209191-18-003958 · doc4.xml · nonDerivative · entry 3 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,724 F1 · kind: Transaction made pursuant to Dr. Chodakewitz's company-approved trading plan under Rule 10b5-1. F3 · price: Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $157.54 (range $156.95 to $157.83). Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 21:38 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
SaleCommon Stock | 519 | $155.80 | $80,860.20 |
DisclosureSEC source: 0001209191-18-003958 · doc4.xml · nonDerivative · entry 2 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,624 F1 · kind: Transaction made pursuant to Dr. Chodakewitz's company-approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $155.80 (range $155.77 to $155.91). F3 · price: Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 21:38 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
Exercise / conversionCommon Stock | 1,719 | $96.87 | $166,519.53 |
DisclosureSEC source: 0001209191-18-003958 · doc4.xml · nonDerivative · entry 1 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,143 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 21:40 UTC |
SMITH IAN FEVP, COO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,125 | $0.00 Strike: $96.87 | $0.00 |
DisclosureSEC source: 0001209191-18-003963 · doc4.xml · derivative · entry 7 SMITH IAN F · CIK 0001197032 · EVP, COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,250 Underlying: Common Stock · 2,125 shares Expires 2024-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option vests in 16 quarterly installments from 7/15/2014. Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 21:40 UTC |
SMITH IAN FEVP, COO
|
SaleCommon Stock | 500 | $159.29 | $79,645.00 |
DisclosureSEC source: 0001209191-18-003963 · doc4.xml · nonDerivative · entry 5 SMITH IAN F · CIK 0001197032 · EVP, COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,888 F1 · kind: Transaction made pursuant to Mr. Smith's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $159.29 (range $158.96 to $159.65). Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 21:40 UTC |
SMITH IAN FEVP, COO
|
SaleCommon Stock | 400 | $158.11 | $63,244.00 |
DisclosureSEC source: 0001209191-18-003963 · doc4.xml · nonDerivative · entry 4 SMITH IAN F · CIK 0001197032 · EVP, COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,388 F1 · kind: Transaction made pursuant to Mr. Smith's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $158.11 (range $157.77 to $158.67). Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 21:40 UTC |
SMITH IAN FEVP, COO
|
SaleCommon Stock | 400 | $157.02 | $62,808.00 |
DisclosureSEC source: 0001209191-18-003963 · doc4.xml · nonDerivative · entry 3 SMITH IAN F · CIK 0001197032 · EVP, COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,788 F1 · kind: Transaction made pursuant to Mr. Smith's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $157.02 (range $156.62 to $157.50). Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 21:40 UTC |
SMITH IAN FEVP, COO
|
SaleCommon Stock | 825 | $155.80 | $128,535.00 |
DisclosureSEC source: 0001209191-18-003963 · doc4.xml · nonDerivative · entry 2 SMITH IAN F · CIK 0001197032 · EVP, COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,188 F1 · kind: Transaction made pursuant to Mr. Smith's company-approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $155.80 (range $155.32 to $156.26). F3 · price: Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 21:40 UTC |
SMITH IAN FEVP, COO
|
Exercise / conversionCommon Stock | 2,125 | $96.87 | $205,848.75 |
DisclosureSEC source: 0001209191-18-003963 · doc4.xml · nonDerivative · entry 1 SMITH IAN F · CIK 0001197032 · EVP, COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,013 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 21:43 UTC |
SACHS BRUCE IDirector
|
GrantDeferred Stock Units · Derivative | 261.905 | $157.50 | $41,250.04 |
DisclosureSEC source: 0001209191-18-003974 · doc4.xml · derivative · entry 1 SACHS BRUCE I · CIK 0001197036 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,119.469 Underlying: Common Stock · 261.905 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) the termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death. F1 · derivative.exercise_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) the termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death. F1 · derivative.expiration_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) the termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death. Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 21:45 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 55,313 | $0.00 Strike: $45.11 | $0.00 |
DisclosureSEC source: 0001209191-18-003981 · doc4.xml · derivative · entry 10 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 55,313 shares Expires 2023-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Fully vested. Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 21:45 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 44,250 | $0.00 Strike: $48.74 | $0.00 |
DisclosureSEC source: 0001209191-18-003981 · doc4.xml · derivative · entry 9 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 44,250 shares Expires 2022-07-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Fully vested. Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 21:45 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 7,995 | $159.39 | $1,274,323.05 |
DisclosureSEC source: 0001209191-18-003981 · doc4.xml · nonDerivative · entry 7 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,497 F1 · kind: Transaction made pursuant to Dr. Leiden's company-approved trading plan under Rule 10b5-1. F3 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $159.39 (range $159.18 to $159.75). Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 21:45 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 17,918 | $158.79 | $2,845,199.22 |
DisclosureSEC source: 0001209191-18-003981 · doc4.xml · nonDerivative · entry 6 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,492 F1 · kind: Transaction made pursuant to Dr. Leiden's company-approved trading plan under Rule 10b5-1. F3 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $158.79 (range $158.18 to $159.16). Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 21:45 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 11,471 | $157.67 | $1,808,632.57 |
DisclosureSEC source: 0001209191-18-003981 · doc4.xml · nonDerivative · entry 5 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,410 F1 · kind: Transaction made pursuant to Dr. Leiden's company-approved trading plan under Rule 10b5-1. F3 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $157.67 (range $157.18 to $158.17). Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 21:45 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 19,808 | $156.62 | $3,102,328.96 |
DisclosureSEC source: 0001209191-18-003981 · doc4.xml · nonDerivative · entry 4 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,881 F1 · kind: Transaction made pursuant to Dr. Leiden's company-approved trading plan under Rule 10b5-1. F3 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $156.62 (range $156.18 to $157.17). Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 21:45 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 42,371 | $155.77 | $6,600,130.67 |
DisclosureSEC source: 0001209191-18-003981 · doc4.xml · nonDerivative · entry 3 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,689 F1 · kind: Transaction made pursuant to Dr. Leiden's company-approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $155.77 (range $155.18 to $156.17). F3 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 21:45 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
Exercise / conversionCommon Stock | 55,313 | $45.11 | $2,495,169.43 |
DisclosureSEC source: 0001209191-18-003981 · doc4.xml · nonDerivative · entry 2 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,060 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 21:45 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
Exercise / conversionCommon Stock | 44,250 | $48.74 | $2,156,745.00 |
DisclosureSEC source: 0001209191-18-003981 · doc4.xml · nonDerivative · entry 1 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,747 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 21:46 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 3,955 | $159.41 | $630,466.55 |
DisclosureSEC source: 0001209191-18-003986 · doc4.xml · nonDerivative · entry 5 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,761 F1 · kind: Transaction made pursuant to Mr. Altshuler's company-approved trading plan under Rule 10b5-1. F3 · price: Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $159.41 (range $159.21 to $159.65). Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 21:46 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 10,585 | $158.82 | $1,681,109.70 |
DisclosureSEC source: 0001209191-18-003986 · doc4.xml · nonDerivative · entry 4 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,716 F1 · kind: Transaction made pursuant to Mr. Altshuler's company-approved trading plan under Rule 10b5-1. F3 · price: Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $158.82 (range $158.21 to $159.20). Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 21:46 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 6,130 | $157.71 | $966,762.30 |
DisclosureSEC source: 0001209191-18-003986 · doc4.xml · nonDerivative · entry 3 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,301 F1 · kind: Transaction made pursuant to Mr. Altshuler's company-approved trading plan under Rule 10b5-1. F3 · price: Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $157.71 (range $157.20 to $158.19). Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 21:46 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 11,767 | $156.63 | $1,843,065.21 |
DisclosureSEC source: 0001209191-18-003986 · doc4.xml · nonDerivative · entry 2 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,431 F1 · kind: Transaction made pursuant to Mr. Altshuler's company-approved trading plan under Rule 10b5-1. F3 · price: Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $156.63 (range $156.19 to $157.18). Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 21:46 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 23,813 | $155.77 | $3,709,351.01 |
DisclosureSEC source: 0001209191-18-003986 · doc4.xml · nonDerivative · entry 1 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,198 F1 · kind: Transaction made pursuant to Mr. Altshuler's company-approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $155.77 (range $155.19 to $156.17). F3 · price: Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| January 12, 2018 Filed Jan 16, 2018 22:01 UTC |
Parini MichaelEVP, CL&AO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,125 | $0.00 Strike: $90.29 | $0.00 |
DisclosureSEC source: 0001209191-18-003628 · doc4.xml · derivative · entry 3 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,250 Underlying: Common Stock · 2,125 shares Expires 2026-07-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests in 16 quarterly installments from 7/12/2016. Read SEC document |
| January 12, 2018 Filed Jan 16, 2018 22:01 UTC |
Parini MichaelEVP, CL&AO
|
SaleCommon Stock | 2,125 | $157.16 | $333,965.00 |
DisclosureSEC source: 0001209191-18-003628 · doc4.xml · nonDerivative · entry 2 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,943 F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. Read SEC document |
| January 12, 2018 Filed Jan 16, 2018 22:01 UTC |
Parini MichaelEVP, CL&AO
|
Exercise / conversionCommon Stock | 2,125 | $90.29 | $191,866.25 |
DisclosureSEC source: 0001209191-18-003628 · doc4.xml · nonDerivative · entry 1 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,068 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 11, 2018 Filed Jan 12, 2018 21:16 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,250 | $0.00 Strike: $109.14 | $0.00 |
DisclosureSEC source: 0001209191-18-003419 · doc4.xml · derivative · entry 4 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,250 Underlying: Common Stock · 4,250 shares Expires 2025-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/03/2015. Read SEC document |
| January 11, 2018 Filed Jan 12, 2018 21:16 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
SaleCommon Stock | 4,250 | $159.00 | $675,750.00 |
DisclosureSEC source: 0001209191-18-003419 · doc4.xml · nonDerivative · entry 2 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,952 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company-approved trading plan under Rule 10b5-1. Read SEC document |
| January 11, 2018 Filed Jan 12, 2018 21:16 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
Exercise / conversionCommon Stock | 4,250 | $109.14 | $463,845.00 |
DisclosureSEC source: 0001209191-18-003419 · doc4.xml · nonDerivative · entry 1 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,202 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 22:33 UTC |
Bhatia Sangeeta N.Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,753 | $0.00 Strike: $126.68 | $0.00 |
DisclosureSEC source: 0001209191-18-002982 · doc4.xml · derivative · entry 3 Bhatia Sangeeta N. · CIK 0001643921 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,247 Underlying: Common Stock · 10,753 shares Expires 2025-06-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests in 16 quarterly installments from 06/04/2015. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 22:33 UTC |
Bhatia Sangeeta N.Director
|
SaleCommon Stock | 10,753 | $156.00 | $1,677,468.00 |
DisclosureSEC source: 0001209191-18-002982 · doc4.xml · nonDerivative · entry 2 Bhatia Sangeeta N. · CIK 0001643921 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,953 F1 · kind: Transaction made pursuant to Dr. Bhatia's company-approved trading plan under Rule 10b5-1. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 22:33 UTC |
Bhatia Sangeeta N.Director
|
Exercise / conversionCommon Stock | 10,753 | $126.68 | $1,362,190.04 |
DisclosureSEC source: 0001209191-18-002982 · doc4.xml · nonDerivative · entry 1 Bhatia Sangeeta N. · CIK 0001643921 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,706 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2018 Filed Jan 3, 2018 21:49 UTC |
Graney ThomasChief Financial Officer
|
SaleCommon Stock | 777 | $149.95 | $116,511.15 |
DisclosureSEC source: 0001209191-18-000968 · doc4.xml · nonDerivative · entry 1 Graney Thomas · CIK 0001618275 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,789 F1 · kind: Transaction made pursuant to Mr. Graney's company-approved trading plan under Rule 10b5-1. Read SEC document |
| January 02, 2018 Filed Jan 3, 2018 21:56 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,438 | $0.00 Strike: $73.51 | $0.00 |
DisclosureSEC source: 0001209191-18-001000 · doc4.xml · derivative · entry 6 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,438 shares Expires 2024-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Fully vested. Read SEC document |
| January 02, 2018 Filed Jan 3, 2018 21:56 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
SaleCommon Stock | 863 | $152.80 | $131,866.40 |
DisclosureSEC source: 0001209191-18-001000 · doc4.xml · nonDerivative · entry 5 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,424 F1 · kind: Transaction made pursuant to Dr. Chodakewitz's company-approved trading plan under Rule 10b5-1. F3 · price: Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $152.80 (range $152.70 to $153.03). Read SEC document |
| January 02, 2018 Filed Jan 3, 2018 21:56 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
SaleCommon Stock | 1,600 | $152.06 | $243,296.00 |
DisclosureSEC source: 0001209191-18-001000 · doc4.xml · nonDerivative · entry 4 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,287 F1 · kind: Transaction made pursuant to Dr. Chodakewitz's company-approved trading plan under Rule 10b5-1. F3 · price: Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $152.06 (range $151.70 to $152.69). Read SEC document |
| January 02, 2018 Filed Jan 3, 2018 21:56 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
SaleCommon Stock | 675 | $150.87 | $101,837.25 |
DisclosureSEC source: 0001209191-18-001000 · doc4.xml · nonDerivative · entry 3 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,887 F1 · kind: Transaction made pursuant to Dr. Chodakewitz's company-approved trading plan under Rule 10b5-1. F3 · price: Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $150.87 (range $150.53 to $151.50). Read SEC document |
| January 02, 2018 Filed Jan 3, 2018 21:56 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
SaleCommon Stock | 300 | $149.65 | $44,895.00 |
DisclosureSEC source: 0001209191-18-001000 · doc4.xml · nonDerivative · entry 2 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,562 F1 · kind: Transaction made pursuant to Dr. Chodakewitz's company-approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $149.65 (range $149.41 to $149.92). F3 · price: Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| January 02, 2018 Filed Jan 3, 2018 21:56 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
Exercise / conversionCommon Stock | 3,438 | $73.51 | $252,727.38 |
DisclosureSEC source: 0001209191-18-001000 · doc4.xml · nonDerivative · entry 1 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,862 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.